493 A randomized open-label phase III clinical trial evaluating the efficacy and safety of T-VEC compared with GM-CSF revealed promising durable clinical benefits with a higher ORR (31.5% vs 6.4%), higher durable response rates (19.0% vs 1.4%), and longer median OS (23.3 months vs 18.9 months) versus GM-CSF alone, as well as favorable safety profile, especially in IIIB-IVM1a melanoma patients
Many people choose it because its selective, gentle, and less likely to cause unwanted hormonal spikes
Is a glutathione injection safe
If my treatment is medication-based, what happens if I stop taking it
Semaglutide Drops and Tablets Vs
If youve seen those headlines and then heard about a friends extraordinary weight loss, you might start to feel that GLP-1s are miracle drugs